After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults, including near elimination of chronic pain and sickling events and improved anemia.

After over a decade of preclinical research and development, a new gene therapy treatment for sickle cell anemia (SCA) is reversing disease symptoms in two adults, including near elimination of chronic pain and sickling events and improved anemia.: https://ift.tt/2G4ISHF Read more... https://ift.tt/2Efqavo